(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XENOVIEW

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

XENOVIEW

ST13

US500000090135724

Class

5, 9, 10

Filing

90135724

Registration

7507918

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

09/17/2024

Trademark type

Word

Nice classes

5, 9, 10

Filing date

08/25/2020

Registration date

09/17/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/17/2024

Last transaction

09/17/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/28/2022

First use in commerce

01/25/2023

Drawing code

4

Owner type

03

Owner location

Research Triangle Park, NC

Examiner

LEE, OLIVIA

Law office

O10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Polarean, Inc.

Representatives

Anthony P. DeRosa MYERS BIGEL, P.A.

Technical classification

Nice Classes

Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Inhalable contrast agents for in-vivo imagingin particularinhalable hyperpolarized Xenon-129 gas delivered to a patient to obtain ventilation and gas exchange image and oscillation data of the patient's lungs; Contrast media for use with imaging medical equipment; Imaging agents for magnetic resonance imaging (MRI)

Class 9

Downloadable computer software for recordingprocessingtransmittingdisplayingand/or analyzing data and images for use in connection with hyperpolarized gas production and delivery systems for medical imagingsystems for providing hyperpolarized Xenon-129 gas used to obtain magnetic resonance imaging (MRI) data of a patient's lungs

Class 10

Hyperpolarized gas production and delivery system for medical imaginga system for producing hyperpolarized Xenon-129 gas used to obtain magnetic resonance imaging (MRI) data of a patient's lungs comprised of a radiological apparatus for diagnostic and medical purposes in the nature of a Xenon-129 hyperpolarizerpolarimetry measurement stations in the nature of polarimetersdose delivery bags that facilitate the delivery of doses of inhalable hyperpolarized Xenon-129 gas

Publications

History of USPTO decisions and trademark events.

47 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

09/17/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/14/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/14/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/21/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/21/2024

ALIE

ASSIGNED TO LIE

06/21/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/16/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

02/06/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

02/06/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/14/2023

GNRT

NON-FINAL ACTION E-MAILED

11/14/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

11/14/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/06/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/17/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/17/2023

IUAF

USE AMENDMENT FILED

09/07/2023

EISU

TEAS STATEMENT OF USE RECEIVED

09/07/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/05/2023

EX4G

SOU EXTENSION 4 GRANTED

04/03/2023

EXT4

SOU EXTENSION 4 FILED

04/03/2023

EEXT

SOU TEAS EXTENSION RECEIVED

04/03/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/28/2022

EX3G

SOU EXTENSION 3 GRANTED

09/26/2022

EXT3

SOU EXTENSION 3 FILED

09/26/2022

EEXT

SOU TEAS EXTENSION RECEIVED

09/26/2022

DOCK

ASSIGNED TO EXAMINER

05/17/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/26/2022

EX2G

SOU EXTENSION 2 GRANTED

03/24/2022

EXT2

SOU EXTENSION 2 FILED

03/24/2022

EEXT

SOU TEAS EXTENSION RECEIVED

03/24/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/22/2021

EX1G

SOU EXTENSION 1 GRANTED

09/20/2021

EXT1

SOU EXTENSION 1 FILED

09/20/2021

EEXT

SOU TEAS EXTENSION RECEIVED

09/20/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/09/2021

PUBO

PUBLISHED FOR OPPOSITION

02/09/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/20/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/04/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

12/29/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/29/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

12/29/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/29/2020

DOCK

ASSIGNED TO EXAMINER

12/22/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/28/2020

NWAP

NEW APPLICATION ENTERED

08/28/2020

Continuous trademark protection

Get notified about every new filing that threatens XENOVIEW or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.